Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California E-Pedigree Phase-In Bill Moving Through State Legislature

Executive Summary

A bill is moving through the California legislature that would delay yet again the implementation of the state's electronic pedigree mandate, offering a phased implementation schedule with a requirement that all drugs come into compliance by 2015

You may also be interested in...



California E-Pedigree Law Pushes Final Implementation Back To 2016

California's latest electronic pedigree law pushes the deadline for all drugs sold in the state to carry track-and-trace information to 2016, a year later than an earlier version that was under consideration

California E-Pedigree Law Pushes Final Implementation Back To 2016

California's latest electronic pedigree law pushes the deadline for all drugs sold in the state to carry track-and-trace information to 2016, a year later than an earlier version that was under consideration

RFID’s Possible Interaction With Biologics Queried By Biogen, Pfizer

Radiofrequency identification appears to hold the most potential to increase the security of the pharmaceutical supply chain, stakeholders advise FDA, but important questions include how the radiofrequency emissions might interact with biologics and certain other kinds of drug products

Related Content

Latest News
UsernamePublicRestriction

Register

PS049801

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel